Literature DB >> 24150199

Plasma leptin and adiponectin concentrations correlate with cardiometabolic risk and systemic inflammation in healthy, non-obese children.

Dimitrios A Stakos, Helena I Papaioannou, Iliana Angelidou, Elpis Mantadakis, Emmanuel Paraskakis, Christina Tsigalou, Athanasios Chatzimichael.   

Abstract

BACKGROUND: Plasma adipocytokines are associated with metabolic profile and cardiovascular risk in obese children.
OBJECTIVE: To investigate the association of plasma leptin and adiponectin concentrations with cardiometabolic risk profile and systemic inflammation in non-obese children.
SUBJECTS: We studied 170 healthy, non-obese children (86 males, mean age 10±2 years).
METHODS: Children's current body mass index (BMI), plasma leptin and adiponectin concentrations, lipid profile, fasting plasma glucose and high sensitivity C reactive protein (hsCRP) were measured.
RESULTS: After adjustment for age, gender and BMI, plasma leptin concentrations were positively associated with hsCRP (t=2.72, p=0.009) and fasting plasma glucose (t=4.27, p<0.0001); plasma adiponectin concentrations were negatively associated with hsCRP (t=-3.31, p=0.0016); and positively with high density lipoprotein cholesterol (t=2.32, p=0.02). Children in the highest quartile of leptin/adiponectin (L/A) ratio demonstrated significantly higher BMI, systolic blood pressure, hsCRP, triglycerides and fasting glucose and the lowest high density lipoprotein (HDL) compared to lower L/A ratio quartiles.
CONCLUSIONS: Alterations in plasma leptin and adiponectin may help to reclassify non-obese children, detecting those with more unfavorable risk profiles independent of BMI status.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24150199     DOI: 10.1515/jpem-2013-0195

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  6 in total

1.  Leptin Elevation as a Risk Factor for Slipped Capital Femoral Epiphysis Independent of Obesity Status.

Authors:  Schuyler J Halverson; Tracy Warhoover; Gregory A Mencio; Steven A Lovejoy; Jeffrey E Martus; Jonathan G Schoenecker
Journal:  J Bone Joint Surg Am       Date:  2017-05-17       Impact factor: 5.284

2.  Pro- and anti-inflammatory adipokines are associated with cardiometabolic risk markers in Brazilian schoolchildren.

Authors:  Mariana De Santis Filgueiras; Milene Cristine Pessoa; Josefina Bressan; Fernanda Martins de Albuquerque; Lara Gomes Suhett; Mariane Alves Silva; Juliana Farias de Novaes
Journal:  Eur J Pediatr       Date:  2021-04-09       Impact factor: 3.183

3.  Neonatal and Adolescent Adipocytokines as Predictors of Adiposity and Cardiometabolic Risk in Adolescence.

Authors:  Catherine O Buck; Nan Li; Charles B Eaton; Karl T Kelsey; Kim M Cecil; Heidi J Kalkwarf; Kimberly Yolton; Bruce P Lanphear; Aimin Chen; Joseph M Braun
Journal:  Obesity (Silver Spring)       Date:  2021-06       Impact factor: 5.002

Review 4.  Atherogenic dyslipidemia and cardiovascular risk factors in obese children.

Authors:  Ebe D'Adamo; Ornella Guardamagna; Francesco Chiarelli; Andrea Bartuli; Daniela Liccardo; Federica Ferrari; Valerio Nobili
Journal:  Int J Endocrinol       Date:  2015-01-12       Impact factor: 3.257

5.  Weight Gain in Infancy and Overweight or Obesity in Childhood across the Gestational Spectrum: a Prospective Birth Cohort Study.

Authors:  Guoying Wang; Sara Johnson; Yiwei Gong; Sarah Polk; Sara Divall; Sally Radovick; Margaret Moon; David Paige; Xiumei Hong; Deanna Caruso; Zhu Chen; Eric Mallow; Sheila O Walker; Guangyun Mao; Colleen Pearson; Mei-Cheng Wang; Barry Zuckerman; Tina L Cheng; Xiaobin Wang
Journal:  Sci Rep       Date:  2016-07-15       Impact factor: 4.379

6.  Serum Amyloid P and Endocrine Markers in a Cohort of Obese Children.

Authors:  Mehwish Anwer; Muhammad J Iqbal
Journal:  Indian J Endocrinol Metab       Date:  2018 Sep-Oct
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.